Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In randomized clinical trials and observational studies, influenza vaccination has been shown to be effective in reducing influenza-related illness, hospitalizations, cardiovascular events, and mortality in select populations. However, the real-world effectiveness of influenza vaccination is limited by its uptake. Conducted during the 2023/2024 influenza season, the first NUDGE-FLU-CHRONIC trial demonstrated the effectiveness of behavioral nudging letters in increasing influenza vaccination rates among adults aged 18-64 years with chronic diseases in Denmark. This present study will once again investigate whether digital behavioral nudges delivered via the official, mandatory Danish electronic letter system can increase influenza vaccine uptake among adults aged 18-64 years with chronic diseases including whether the effectiveness of the previously successful strategies can be confirmed during a subsequent influenza season.
The study is a prospective, randomized, open-label implementation trial. The study population will consist of persons aged 18-64 years identified as eligible for free-of-charge influenza vaccination due to a chronic condition. Subjects will be identified through Danish nationwide health registries using codes from the International Classification of Diseases, 10th revision (ICD-10). Individuals will be randomized to 1 of 7 arms (1 usual care arm and 6 intervention arms) with each testing different nudging strategies employing various behavioural economic principles. The interventions will be delivered through the official, mandatory Danish electronic letter system. All subject data will be retrieved from the Danish nationwide registries with the exception of information on intervention allocation. Endpoints will be retrieved at prespecified dates using prespecified search algorithms.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Usual Care | No Intervention | No letter | |
| Standard Letter | Experimental | This group will receive a standard letter on the benefits of influenza vaccination without behavioral economic enhancement |
|
| Repeated Letter | Experimental | The standard letter sent out two times instead of once |
|
| Cardiovascular Gain-Framing Letter | Experimental | Text added to the standard letter highlighting potential cardiovascular benefits of influenza vaccination |
|
| Repeated Cardiovascular Gain-Framing Letter | Experimental | The cardiovascular gain-framing letter sent out two times instead of once |
|
| Respiratory Gain-Framing Letter | Experimental |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Behavioral Economic Principles | Behavioral | The control arm will receive no letter to reflect the background vaccination uptake. Intervention arms will test the effects of different letters developed using behavioral economic principles. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants who received an influenza vaccine | Up to 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Time from intervention delivery to influenza vaccination | Up to 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with laboratory-confirmed influenza | Up to 8 months | |
| Number of participants with a hospitalization for influenza or pneumonia | Up to 8 months | |
Inclusion Criteria:
Age 18-64 years
Must be registered in the Danish nationwide registries as meeting at least one of the following eligibility criteria for free-of-charge influenza vaccination in the Danish public health system:
Access to the official, mandatory Danish electronic mailbox system
Exclusion Criteria:
None
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tor Biering-Sørensen, MD, MSc, MPH, PhD | Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte | Hellerup | Capital Region | 2900 | Denmark |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41213006 | Derived | Johansen ND, Vaduganathan M, Bhatt AS, Modin D, Claggett BL, Janstrup KH, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Kober L, Solomon SD, Sivapalan P, Jensen JUS, Martel CJ, Krause TG, Biering-Sorensen T. Digital Nudges to Increase Influenza Vaccination in Patients with Chronic Diseases. NEJM Evid. 2026 Jan;5(1):EVIDoa2500265. doi: 10.1056/EVIDoa2500265. Epub 2025 Nov 10. |
Not provided
Not provided
Data will be collected from Danish administrative health registries, which are subject to Danish legislation and can only be made available to a third party under certain conditions. Please contact the sponsor-investigator in case of any inquiries.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Text added to the standard letter highlighting potential respiratory disease-related benefits of influenza vaccination
|
| Implementation Intention Prompt Letter | Experimental | Implementation intention prompt added to the standard letter |
|
| Number of participants with a hospitalization for any respiratory disease |
| Up to 8 months |
| Number of participants with a hospitalization for any cardio-respiratory disease | Up to 8 months |
| Number of participants with a hospitalization for any cardiovascular disease | Up to 8 months |
| Number of participants with any hospitalization | Up to 8 months |
| Total number of hospitalizations (first and recurrent) | Up to 8 months |
| All-cause mortality | Up to 8 months |
| Composite of incident heart failure, heart failure hospitalization, or cardiovascular death | Up to 8 months |
| Composite of myocardial infarction, stroke, or cardiovascular death | Up to 8 months |
| Composite of myocardial infarction, coronary revascularization, stroke, or cardiovascular death | Up to 8 months |
| Number of participants with incident heart failure or heart failure hospitalization | Up to 8 months |
| Total number of heart failure events (incident heart failure and first and recurrent heart failure hospitalizations) | Up to 8 months |
| Cardiovascular death | Up to 8 months |
| Number of participants with myocardial infarction | Up to 8 months |
| Number of participants with coronary revascularization | Up to 3 months |
| Number of participants with stroke | Up to 8 months |
| Number of participants with incident atrial fibrillation or atrial fibrillation hospitalization | Up to 8 months |
| Number of contacts to general practitioner (excluding vaccination visit) | Up to 8 months |
| Number of participants with laboratory-confirmed COVID-19 | Up to 8 months |
| Number of participants with a hospitalization for COVID-19 | Up to 8 months |
| Number of participants who received a COVID-19 vaccine | Up to 3 months |
| Number of participants who filled a prescription for any guideline-directed medical therapy for heart failure | Up to 8 months |
| Total number of filled prescriptions for guideline-directed medical therapy for heart failure | Up to 8 months |
| Number of participants who filled a prescription for a sodium-glucose cotransporter 2 inhibitor or glucagon-like peptide 1 receptor agonist | Up to 8 months |
| ID | Term |
|---|---|
| D007251 | Influenza, Human |
| D001519 | Behavior |
| ID | Term |
|---|---|
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D009976 | Orthomyxoviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided